RYZUMVI

Growth

phentolamine mesylate

NDAOPHTHALMICSOLUTION

Approved

Sep 2023

Lifecycle

Growth

Competitive Pressure

0/100

Loss of Exclusivity

LOE Date

Dec 25, 2039

168 months away

Patent Expiry

Dec 25, 2039

Exclusivity Expiry

Sep 25, 2026

Patent Records (5)

Patent #	Expiry	Type	Use Code
9795560	Jan 31, 2034	Product	—
10772829	Jan 31, 2034	Product	—
11090261	Jan 31, 2034	Product	—
11844858	Jan 31, 2034	Product	—
12350366	Jan 31, 2034	Product	—

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers